N, Kontos MC, Lawler PR, Menon V, Metkus TS, Ng J, Orgel R, Overgaard CB, Park JG, Phreaner N, Roswell RO, Schulman SP, Jeffrey Snell R, Solomon MA, Ternus B, Tymchak W, Vikram F, Morrow DA. Epidemiology of Shock in Contemporary Cardiac Intensive Care Units. Circ Cardiovasc Qual Outcomes. 2019 Mar;12(3):e005618. \[[PMC free article: PMC11032172](/pmc/articles/PMC11032172/)\] \[[PubMed: 30879324](https://pubmed.ncbi.nlm.nih.gov/30879324)\] 4. Standl T, Annecke T, Cascorbi I, Heller AR, Sabashnikov A, Teske W. The Nomenclature, Definition and Distinction of Types of Shock. Dtsch Arztebl Int. 2018 Nov 09;115(45):757-768. \[[PMC free article: PMC6323133](/pmc/articles/PMC6323133/)\] \[[PubMed: 30573009](https://pubmed.ncbi.nlm.nih.gov/30573009)\] 5. Gabbay U, Carmi D, Birk E, Dagan D, Shatz A, Kidron D. The Sudden Infant Death Syndrome mechanism of death may be a non-septic hyper-dynamic shock. Med Hypotheses. 2019 Jan;122:35-40. \[[PubMed: 30593418](https://pubmed.ncbi.nlm.nih.gov/30593418)\] 6. Smith MD, Maani CV. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): May 8, 2023. Norepinephrine. \[[PubMed: 30725944](https://pubmed.ncbi.nlm.nih.gov/30725944)\] 7. Casey JD, Brown RM, Semler MW. Resuscitation fluids. Curr Opin Crit Care. 2018 Dec;24(6):512-518. \[[PMC free article: PMC6503665](/pmc/articles/PMC6503665/)\] \[[PubMed: 30247219](https://pubmed.ncbi.nlm.nih.gov/30247219)\] 8. Mendelson J. Emergency Department Management of Pediatric Shock. Emerg Med Clin North Am. 2018 May;36(2):427-440. \[[PubMed: 29622332](https://pubmed.ncbi.nlm.nih.gov/29622332)\] 9. Silva J, Gon√ßalves L, Sousa PP. Fluid therapy and shock: an integrative literature review. Br J Nurs. 2018 Apr 26;27(8):449-454. \[[PubMed: 29683753](https://pubmed.ncbi.nlm.nih.gov/29683753)\] 10. Hooper N, Armstrong TJ. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Sep 26, 2022. Hemorrhagic Shock. \[[PubMed: 29262047](https://pubmed.ncbi.nlm.nih.gov/29262047)\] 11. Vincent JL, Leone M. Optimum treatment of vasopressor-dependent distributive shock. Expert Rev Anti Infect Ther. 2017 Jan;15(1):5-10. \[[PubMed: 27774825](https://pubmed.ncbi.nlm.nih.gov/27774825)\] 12. Ince C. The rationale for microcirculatory guided fluid therapy. Curr Opin Crit Care. 2014 Jun;20(3):301-8. \[[PubMed: 24758985](https://pubmed.ncbi.nlm.nih.gov/24758985)\] 13. Lodha R, Kapoor V. Peripheral circulatory failure. Indian J Pediatr. 2003 Feb;70(2):163-8. \[[PubMed: 12661813](https://pubmed.ncbi.nlm.nih.gov/12661813)\] 14. Roumpf SK, Hunter BR. Does the Addition of Vasopressin to Catecholamine Vasopressors Affect Outcomes in Patients With Distributive Shock? Ann Emerg Med. 2019 Jul;74(1):153-155. \[[PubMed: 30446352](https://pubmed.ncbi.nlm.nih.gov/30446352)\] 15. Nedel WL, Rech TH, Ribeiro RA, Pellegrini JAS, Moraes RB. Renal Outcomes of Vasopressin and Its Analogs in Distributive Shock: A Systematic Review and Meta-Analysis of Randomized Trials. Crit Care Med. 2019 Jan;47(1):e44-e51. \[[PubMed: 30303842](https://pubmed.ncbi.nlm.nih.gov/30303842)\] **Disclosure:** Nicholas Smith declares no relevant financial relationships with ineligible companies. **Disclosure:** Richard Lopez declares no relevant financial relationships with ineligible companies. **Disclosure:** Michael Silberman declares no relevant financial relationships with ineligible companies.